Stimulating T cell surface receptor 4-1BB enhances mitochondrial fusion and biogenesis in CD8+ tumor-infiltrating lymphocytes, independently of PGC-1α and p38-MAPK signaling (16). The gene discussed is CD8A; the disease is neoplasm.